Caligan Partners LP - Jun 29, 2023 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Role: 10%+ Owner
Signature: Caligan Partners LP, By: /s/ David Edward Johnson, Partner
Stock symbol: LAB
Transactions as of: Jun 29, 2023
Transactions value $: $0
Form type: 4
Date filed: 7/3/2023, 05:18 PM
Previous filing: Dec 30, 2022
Next filing: Aug 11, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LAB	Common Stock, $0.001 par value per share ("Common Stock")	Other		-109K	-1.27%		8.47M	Jun 29, 2023	See footnote	F1, F2
transaction	LAB	Common Stock	Other		-670K	-7.92%		7.8M	Jul 3, 2023	See footnote	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the total number of shares of Common Stock beneficially owned by Caligan Partners LP ("Caligan") following the termination of an investment management agreement with respect to an account previously managed by Caligan.
F2	The securities reported herein are held by an affiliated fund of Caligan. David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan.
F3	This transaction represents an in-kind distribution by certain funds and accounts to which Caligan serves as the investment manager.

Remarks:

The Reporting Persons disclaim beneficial ownership in the securities reported on this Form 4 except to the extent of his or its pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that any of the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 or for any other purpose.